Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net earnings	$ 268,563	$ 251,531
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	250,956	244,877
Stock-based compensation expense	22,435	21,198
Change in estimated sales allowances	180,391	38,861
Deferred income tax benefit	(57,076)	(54,005)
Other non-cash items	118,935	33,593
Litigation settlements, net	(10,033)	26,210
Changes in operating assets and liabilities:
Accounts receivable	(288,011)	(300,200)
Inventories	(109,639)	(139,998)
Trade accounts payable	(8,975)	55,559
Income taxes	(32,837)	81,301
Deferred revenue	(14,645)	0
Other operating assets and liabilities, net	(127,426)	(115,581)
Net cash provided by operating activities	192,638	143,346
Cash flows from investing activities:
Capital expenditures	(98,918)	(111,413)
Purchase of marketable securities	(7,957)	(2,890)
Proceeds from sale of marketable securities	6,568	571
Other items, net	(62,622)	2,132
Net cash used in investing activities	(162,929)	(111,600)
Cash flows from financing activities:
Purchase of common stock	(499,953)	(349,998)
Change in short-term borrowings, net	283,108	4,924
Proceeds from issuance of long-term debt	835,000	0
Payment of long-term debt	(732,549)	(2,466)
Proceeds from exercise of stock options	27,676	61,166
Other items, net	4,335	4,020
Net cash used in financing activities	(82,383)	(282,354)
Effect on cash of changes in exchange rates	(8,052)	23,495
Net decrease in cash and cash equivalents	(60,726)	(227,113)
Cash and cash equivalents - beginning of period	375,056	662,052
Cash and cash equivalents - end of period	$ 314,330	$ 434,939